Postoperative Transfusion in Massive Weight Loss Body Contouring Surgery: A Single-center Retrospective Cohort Study Authors: Maria Albuquerque, Bernardo Cavadas, Miguel Veríssimo, Luís Vieira, Luís Mata Ribeiro, Joaquim Bexiga Published: 2026 ABSTRACT Background:Patients undergoing body contouring after massive weight loss (MWL) are at an increased risk for anemia and perioperative complications. However, data regarding transfusion patterns and procedure-related transfusion burden in this population remain limited.Methods:We retrospectively reviewed 224 MWL patients who underwent 385 procedures at a single tertiary referral center from January 2021 to December 2022. Demographic, hematologic, and surgical variables were analyzed. Procedures were categorized as lower body lift (LBL), other multiple combined procedures, or single procedures. The primary outcome was postoperative transfusion, defined by hemoglobin less than 7.5 g/dL with symptoms or persistent decline. Exploratory multivariable logistic regression analysis was performed to evaluate associations between procedure type and postoperative transfusion while accounting for the limited number of events. This study adheres to STROBE reporting guidelines.Results:Fourteen patients (6.3%) required transfusion. Most transfusions occurred in patients undergoing LBL procedures (9 of 14). In exploratory multivariable analysis, LBL remained associated with transfusion (odds ratio: 3.69; 95% confidence interval: 1.19–11.43; P = 0.024). No statistically significant associations were observed with operative time, number of procedures, or comorbidities, although the limited number of events restricted interpretation of secondary variables. Transfused patients had significantly longer hospital stays.Conclusions:Postoperative transfusion in MWL body contouring was uncommon in this optimized single-center cohort but occurred predominantly in patients undergoing LBL procedures. These findings describe procedural patterns associated with transfusion burden in extensive circumferential procedures and may contribute to perioperative awareness and planning in MWL body contouring surgery. Takeaways Question: What are the procedural patterns and clinical burden associated with postoperative transfusion in massive weight loss body contouring surgery? Findings: In a retrospective cohort of 224 patients undergoing 385 procedures, postoperative transfusion occurred in 6.3% of cases. Transfusion events occurred predominantly in patients undergoing lower body lift procedures and were associated with prolonged hospitalization. Meaning: Postoperative transfusion after massive weight loss body contouring surgery was uncommon overall but clustered predominantly in extensive circumferential procedures. INTRODUCTION Massive weight loss (MWL), whether through bariatric surgery or intensive dietary changes, results in dramatic improvements in metabolic health but often leaves patients with redundant, ptotic skin, and significant contour deformities. These sequelae are not exclusively aesthetic; they frequently cause functional limitations such as intertriginous rashes, hygiene difficulties, impaired mobility, and psychological distress. Consequently, a growing number of MWL patients pursue body contouring surgery to restore physical form and function.1 However, these patients represent a unique surgical population with altered physiology. Nutritional deficiencies are common following bariatric procedures, particularly gastric bypass and sleeve gastrectomy, and may include iron, folate, vitamin B12, and vitamin K deficiencies.2–5 These imbalances contribute to chronic anemia, coagulopathies, and impaired wound healing.6 Furthermore, altered platelet function and increased thromboembolic risk have been reported in this group, although their direct impact on perioperative bleeding is not well understood.6 The complexity of post-MWL body contouring procedures is further amplified by the frequent need for extensive or staged operations involving multiple anatomical regions. These procedures are often lengthy, involve significant tissue undermining, and may result in greater intraoperative blood loss compared to standard aesthetic procedures.7–9 Given these factors, MWL patients are presumed to be at increased risk for blood transfusion—an outcome associated with additional morbidity and healthcare use. Despite this, data regarding transfusion burden and perioperative transfusion patterns in this population remain limited, and existing studies frequently include heterogeneous procedures and perioperative protocols, making interpretation across procedural subgroups difficult. The literature regarding transfusion after body contouring surgery in MWL patients remains relatively limited, particularly in cohorts including heterogeneous post–weight loss etiologies and multiple procedure types managed within standardized perioperative protocols. Previous studies have identified higher transfusion rates in more extensive circumferential procedures; however, the procedural distribution of transfusion events and their clinical impact remain incompletely characterized.4,7 The aim of this study was to describe postoperative transfusion rates in a consecutive cohort of MWL patients undergoing body contouring surgery, to examine procedural patterns associated with transfusion, and to evaluate its clinical impact on postoperative hospitalization within a standardized institutional setting. METHODS This study adheres to STROBE guidelines. (See appendix, Supplemental Digital Content 1, which displays the checklist of items that should be included in reports of cohort studies, https://links.lww.com/PRSGO/F233.) We conducted a retrospective review of all MWL patients undergoing body contouring procedures at a single tertiary hospital from January 2021 to December 2022. Inclusion criteria were body mass index (BMI) less than or equal to 30 kg/m2 (or 36 kg/m2 for functional panniculectomies), and greater than or equal to 20% total weight loss. Revision cases or incomplete data were excluded. Data collected included demographics, comorbidities, smoking status, post–weight loss etiology, preoperative hemoglobin, type of surgery, and duration of surgery. Preoperative anemia was defined as hemoglobin less than 12 g/dL in women and less than 13 g/dL in men. Procedures were classified into (1) LBL, (2) other combined procedures (2 or more anatomical regions excluding LBL), and (3) single procedures (involving only 1 anatomical region, such as arms, breasts, abdomen, thighs, or buttocks). All abdominoplasty procedures were performed through a low transverse incision and included routine plication of the rectus abdominis fascia, umbilical transposition, and layered wound closure in 3 planes. Fleur-de-lis abdominoplasty was reserved in our center for patients with significant vertical skin redundancy, which did not apply to any patient in this cohort. No liposuction was associated with the abdominoplasties included in this study. Combined procedures most frequently included mastopexy, brachioplasty, thigh lift, and abdominoplasty in various combinations. All patients received mechanical venous thromboembolism prophylaxis according to our institutional protocol, including intraoperative and postoperative intermittent pneumatic compression devices and early mobilization. Pharmacologic prophylaxis with low molecular weight heparin (enoxaparin) was routinely administered after abdominoplasty, isolated thigh lift, and all combined procedures. Other single procedures received mechanical measures only. A formal Caprini score was not calculated. The primary outcome was postoperative transfusion based on institutional criteria: hemoglobin less than 7.5 g/dL with symptoms or ongoing decline. Secondary outcomes included complications and hospital length of stay. Continuous variables used descriptively were reported as mean ± SD or median (interquartile range [IQR]), as appropriate. Categorical variables were summarized as n (%). Group comparisons were performed using the Mann–Whitney U test for continuous variables and the Fisher exact test for categorical variables. Given the exploratory nature of the analysis and the limited number of transfusion events, multivariable logistic regression was restricted to minimize overfitting and should be interpreted cautiously. Variables with P < 0.20 in univariate analysis were considered for inclusion in the restricted multivariable model. Formal goodness-of-fit testing was not performed because of sparse outcome events. Statistical significance was set at a P value less than 0.05. All analyses were conducted using IBM SPSS Statistics, version 29. Cases with incomplete data for variables of interest were excluded from the corresponding analyses. RESULTS In total, 224 patients were included in the study, undergoing 385 body contouring procedures. The majority were female (93.0%), with a mean age of 47.8 years (range: 21–73 y). Mean BMI was 25.9 kg/m2, and average weight loss was 41.6%. Most patients (89%) had undergone bariatric surgery, primarily gastric bypass (71.0%) or sleeve gastrectomy (18.0%). Baseline characteristics are summarized in Table 1. Table 1.Patient Demographics and Preoperative CharacteristicsVariablen (%)Age, y Mean ± SD47.8 ± 9.6 Range21.0–73.0Sex Male16 (7.1) Female208 (92.9)Preoperative hemoglobin (g/dL) Mean ± SD12.8 ± 1.4 Range8.7–16.5BMI, kg/m2 Mean ± SD25.9 ± 3.0 Range18.4–36Weight loss, % Mean ± SD41.6 ± 7.9 Range20.0–67.0Weight loss method Diet24 (10.7) Surgery200 (89.3)Comorbidities Smoking39 (17.3) Anemia56 (24.9) Hypertension56 (24.9) Psychiatric disorder78 (34.7) Patient Demographics and Preoperative Characteristics Fourteen (6.3%) patients required postoperative blood transfusion. Detailed clinical characteristics of these patients are provided in Table 2. All transfusions occurred within the first 24–48 postoperative hours; no intraoperative transfusions were performed. Among transfused patients, 9 underwent LBL, 3 had isolated abdominoplasty procedures, and 2 underwent other combined procedures (eg, brachioplasty with buttock lift and brachioplasty with abdominoplasty). Table 2.Clinical Characteristics of the Transfused PatientsProcedureSurgery Duration (min)Hb Preoperative (g/dL)No. Units TransfusedLength of Stay (d)Postoperative ComplicationsLBL36012.1212Hematoma + suture dehiscenceLBL36012.0210SeromaLBL42012.526Hematoma + suture dehiscenceLBL48012.016NoneLBL27012.625Active bleedingLBL30014.125Suture dehiscenceLBL33012.524NoneLBL30014.033Seroma + suture dehiscence + infectionLBL33014.523NoneBrachioplasty + abdominoplasty21014.327Hematoma + suture dehiscenceBrachioplasty + gluteoplasty27013.324NoneAbdominoplasty24012.926HematomaAbdominoplasty22512.325HematomaAbdominoplasty24013.325Hematoma Clinical Characteristics of the Transfused Patients To better characterize the distribution of transfusion events according to procedure type, patients were stratified into 3 groups: LBL (n = 78), other combined procedures (n = 83), and single procedures (n = 63). The specific combinations within the “other combined procedures” group were also identified and their frequencies summarized (Table 3). Transfusion rates were 11.5%, 2.4%, and 4.8%, respectively (Table 4). LBL accounted for the majority of transfusion events and demonstrated statistical association with transfusion in univariate analysis (P = 0.022). Table 3.Distribution of Combined ProceduresCombined Proceduresn (%)Abdominoplasty + mastopexy25 (30.9)Brachioplasty + thigh lift17 (21)Brachioplasty + mastopexy13 (16.0)Abdominoplasty + thigh lift8 (9.9)Abdominoplasty + brachioplasty8 (9.9.)Thigh lift + mastopexy4 (4.9)Thigh lift + gluteoplasty3 (3.7)Brachioplasty + gluteoplasty3 (3.7)Brachioplasty + thigh lift + mastopexy1 (1.2)Abdominoplasty + gluteoplasty1 (1.2)Total83 (100) Distribution of Combined Procedures Table 4.Grouped Surgical Procedures and Transfusion RatesProcedure Categoryn (%)No. Transfusions (%)LBL78 (34.8)9 (11.5)Other multiple procedures83 (37.0)2 (2.4)Single procedures63 (28.1)3 (4.8) Grouped Surgical Procedures and Transfusion Rates In exploratory multivariable analysis, LBL remained associated with postoperative transfusion (odds ratio [OR] = 3.69; 95% confidence interval: 1.19–11.43; P = 0.024). No statistically significant associations were observed with age, sex, smoking, BMI, comorbidities, number of procedures, or operative time. Preoperative hemoglobin was not significantly associated with postoperative transfusion (OR = 0.95; P = 0.787). Table 5 presents a comparison of key baseline and perioperative characteristics between transfused and nontransfused patients. Table 5.Comparison of Transfused Versus Nontransfused PatientsVariableTransfused (n = 14)Nontransfused (n = 210) P Age (y), mean ± SD46.1 ± 11.347.9 ± 10.90.367BMI (kg/m2), mean ± SD25.8 ± 2.225.9 ± 3.00.772Preoperative hemoglobin (g/dL), mean ± SD12.7 ± 1.412.8 ± 1.40.791Preoperative anemia, %28.625.00.761Smoking, %21.417.10.704Multiple procedures, %78.671.00.541Operative time (min), median (IQR)150 (135–160)150 (120–200)0.492Length of stay (d), median (IQR)4 (4–7)3 (2–4)0.001 Comparison of Transfused Versus Nontransfused Patients Patients who received transfusions had significantly longer hospital stays compared to those who did not (median 4 d [IQR 4–7] versus 3 d [IQR 2–4]; P = 0.001). Among patients undergoing LBL, transfusion extended hospitalization by an average of 3.2 days. In the abdominoplasty subgroup, transfusion prolonged stay by nearly 2 days. Median operative time did not differ significantly between transfused and nontransfused patients (150 min [IQR 135–160] versus 150 min [IQR 120–200], P = 0.492). Postoperative complications occurred in 22.0% of patients, with wound dehiscence being the most common. Other complications included seroma (11.6%), hematoma (4.9%), infection (3.1%), and active bleeding (3.6%). Seventeen (7.6%) patients required reoperation, and 4 (1.8%) underwent reoperation specifically due to postoperative bleeding. Only one patient undergoing reoperation for postoperative bleeding required transfusion. On average, transfused patients received 2 units of blood (range: 1–4), and 2 (0.9%) were readmitted due to symptomatic anemia. Complete complication data are presented in Table 6. Table 6.Postoperative ComplicationsComplicationsn (%)Suture dehiscence80 (35.7)Seroma26 (11.6)Hematoma11 (4.9)Active bleeding8 (3.6)Infection7 (3.1)Reoperation under general anesthesia32 (14.2) Postoperative Complications No postoperative mortality was reported in this cohort. DISCUSSION This single-center cohort provides a descriptive evaluation of postoperative transfusion after body contouring surgery in MWL patients managed within a standardized institutional protocol. Transfusion was relatively uncommon, occurred predominantly during the early postoperative period, and was observed mainly in patients undergoing LBL procedures. Although LBL remained associated with transfusion in exploratory multivariable analysis, this finding should be interpreted as reflecting a broader procedural context and operative complexity rather than a direct causal relationship. In our center, LBL is performed circumferentially, combining posterior excision of a belt like dermoadipose segment with standard anterior abdominoplasty. Posteriorly, dermoadipose flaps are first de-epithelialized, followed by suprafascial excision of the surrounding skin and subcutaneous tissue and dissection of a deep gluteal pocket, into which the flaps may be advanced and secured to achieve autologous gluteal augmentation in selected patients, according to previously described techniques.10 Although undermining is kept to a minimum, this approach inherently involves extensive tissue excision, wide operative fields, patient repositioning, and prolonged procedures, all of which may contribute to increased transfusion burden. These technical and perioperative characteristics likely overlap and may explain why LBL functions as a surrogate marker of procedural complexity within this cohort. Previous studies have also reported higher transfusion rates in circumferential procedures.4,7,11,12 Our findings contextualize this observation within a consecutively treated and systematically optimized MWL cohort managed under standardized institutional transfusion criteria. Nevertheless, the present dataset does not allow determination of the specific intraoperative contributors underlying this association. From a clinical perspective, recognition of these procedural patterns may support individualized perioperative planning and patient counseling, particularly in patients undergoing extensive circumferential procedures.4,11 In selected patients with more severe deformities, staging can be considered on a case-by-case basis. The observed transfusion rate (6.3%) was lower than previously reported (8.3%–25%),1,4,7,12 potentially reflecting structured preoperative assessment, hemoglobin optimization, and institutional experience. All anemic patients were evaluated by a hematologist, and optimization targeted the underlying etiology with vitamin B12 or folic acid supplementation, or intravenous iron in cases of iron deficiency. In our institution, patients with a preoperative hemoglobin level less than 10 g/dL are not eligible for body contouring surgery; therefore, surgery was deferred until hematologic optimization was achieved. The relatively low transfusion burden observed in this cohort may also reflect the use of standardized perioperative optimization protocols and uniform institutional transfusion criteria. No statistically significant associations were observed with operative time, combined procedures, or other secondary variables frequently presumed to influence perioperative bleeding. However, given the limited number of transfusion events, the study was not powered to reliably exclude smaller or secondary effects, and the absence of statistical significance should not be interpreted as evidence of absence of association. Transfusion was associated with significantly prolonged hospital stay, particularly in LBL patients, reinforcing transfusion as a clinically relevant postoperative burden in MWL body contouring surgery.7,12 Although antiplatelet therapy was not significantly associated with transfusion, 2 of the 5 patients on such medication did require transfusion, both following LBL. Although not conclusive, this observation reinforces the need for caution in patients who cannot temporarily suspend antiplatelet therapy, particularly those at intermediate or high thrombotic risk.13 Most patients in our study had undergone bariatric surgery (89.0%), predominantly gastric bypass or sleeve gastrectomy. Although sleeve gastrectomy patients demonstrated numerically higher complication rates (59.0%) than bypass patients (43.0%), these differences were not significant. These observations may nevertheless reflect the known nutritional and metabolic alterations associated with bariatric surgery.14–17 These findings may contribute to future prospective studies aimed at improving perioperative assessment and blood-management strategies in post–weight loss body contouring surgery. Limitations This study is limited by its retrospective design and by the low number of transfusion events, which restricts interpretation of multivariable analysis. In addition, several intraoperative variables potentially relevant to transfusion risk, including estimated blood loss, resection weight, fluid administration, and antifibrinolytic use were not consistently available for analysis. Finally, the inclusion of highly optimized patients managed within standardized institutional protocols may limit generalizability to broader MWL populations. CONCLUSIONS Postoperative transfusion after body contouring surgery in MWL patients was uncommon in this optimized single-center cohort but occurred predominantly in patients undergoing LBL procedures. These findings do not establish causal predictors of transfusion but rather describe procedural patterns associated with increased transfusion burden in more extensive circumferential procedures. Recognition of these patterns may support perioperative awareness and future prospective studies incorporating detailed intraoperative variables and standardized blood-management protocols. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. PATIENT CONSENT Informed consent was waived by the institutional ethics committee due to the retrospective nature of the study. ETHICAL APPROVAL This study was approved by the institutional ethics committee and was conducted in accordance with the Declaration of Helsinki. Supplementary Material